Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy
Keti Bardhi, Shelby Coates, Christy J. W. Watson, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1443-1460
Open Access | Times Cited: 21

Showing 21 citing articles:

Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 57
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 22
Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users
Jessica Wright, Linda Huang, Basant E. Katamesh, et al.
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access | Times Cited: 2
A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management
Shampa Ghosh, Jitendra Kumar Sinha, Soumya K. Ghosh, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 35
The Role of Cannabidiol in Liver Disease: A Systemic Review
Si Chen, Jeon-Kyung Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2370-2370
Open Access | Times Cited: 10
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
Dolly Andrea Caicedo, Clara Pérez‐Mañá, Magı́ Farré, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 319-319
Open Access | Times Cited: 1
An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products
Sarunya Kitdumrongthum, Dunyaporn Trachootham
Molecules (2023) Vol. 28, Iss. 6, pp. 2791-2791
Open Access | Times Cited: 20
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 7
Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy
Mendhi Henna Dasram, Pavesan Naidoo, Roderick B. Walker, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1371-1371
Open Access | Times Cited: 5
Evaluation of potential drug–drug interactions with medical cannabis
Jessie Jia Yi Ho, C.Y. Goh, Caitlin Shen Ai Leong, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 5
Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review
Sarah A. Smith, Gia Han Le, Kayla M. Teopiz, et al.
Drug Metabolism Reviews (2024) Vol. 56, Iss. 2, pp. 164-174
Closed Access | Times Cited: 4
Cannabis médical : quoi de neuf ?
Isabelle Nègre
Douleurs Évaluation - Diagnostic - Traitement (2025)
Closed Access
Utilization of Cannabidiol in Post-Organ-Transplant Care
Sachiko Koyama, Jumar Etkins, Jin-Sun Jun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 699-699
Open Access
Cannabinoids as Potential Multitargeting Neuroprotectants in Neuropathic Pain: Exploring the Interplay between Cannabinoid System and Autophagy
Heba‐Tallah Abd Elrahim Abd Elkader, Sara El Idrissi, Sana Sellami, et al.
IntechOpen eBooks (2025)
Closed Access
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies
Elena Rafailovska, Elona Xhemaili, Zorica Naumovska, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 446-446
Open Access
Pharmacological and morphological features and socioeconomic aspects of cannabidiol: A literature review
Oles-Pylyp Hasiuk
International Journal of Medicine and Medical Research (2023), pp. 47-59
Open Access | Times Cited: 4
Inhibition of Uridine 5′-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies
Sonal Pande, Chirag Patel, Tejas M. Dhameliya, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs
Adrian Andrzej Chrobak, Jarosław Woroń, Marcin Siwek
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The influence of lifestyle factors on serum etonogestrel concentrations among contraceptive implant users
Aaron Lazorwitz, Jeanelle Sheeder, Stephanie Teal
Contraception (2024) Vol. 140, pp. 110539-110539
Closed Access
Drug interactions with Cannabis sativa: Mechanisms and clinical implication
Atena Hasanpoor, Maryam Akaberi, Prashant Kesharwani, et al.
Annales de Toxicologie Analytique (2023) Vol. 36, Iss. 2, pp. 131-144
Closed Access | Times Cited: 1

Ibrahim Bechri, Ali Derkaoui, Abdelkarim Shimi, et al.
International Journal of Medicine and Medical Research (2023) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top